journal article·2024-10Open access

Flying‐Saucer‐Shaped Nanoheterojunctions with Enhanced Colorectal Tumor Accumulation for Increased Oxidative Stress and Immunometabolic Regulation

Ya Ma, Yingui Cao, Menghang Zu, Qiang Gao, Ga Liu, Jianying Ji, Haiting Xu, Qiang Yang, Xiaoxiao Shi, Rui L. Reis, Subhas C. Kundu, Ji Zheng, Zhou Li, Bo Xiao

Advanced Functional Materials· Volume 34· Issue 41

Abstract

Abstract The treatment outcomes of nanomedicines against colorectal cancer are severely restricted by their insufficient accumulation in the tumor tissues, unsatisfactory antitumor effect, and weak immunometabolic modulation. To address these issues, flying‐saucer‐shaped nanoheterojunctions by coating copper oxide (CuxO) onto the surface of PEGylated zinc oxide (ZnO) nanoparticles are constructed. When exposed to ultrasound, the resultant CuxO@ZnO nanoheterojunctions exhibit increased locomotor activities, facilitating colorectal mucus infiltration, deep tumor penetration, and tumor cell internalization. The decoration of CuxO suppresses the rapid recombination of electrons and holes in CuxO@ZnO exposed to ultrasound, promoting the production of singlet oxygen and hydroxyl radical, which are generated by CuxO through a Fenton‐like chemodynamic reaction and CuxO@ZnO through sonodynamic reaction. After rectal administration, the sono‐chemodynamic CuxO@ZnO plus PD‐L1 antibodies effectively inhibit the growth of orthotopic and distant tumors. It elicits immunometabolic responses by inducing immunogenic cell death, activating the interferon genes signaling pathway stimulator, and inhibiting glucose transport and the glycolytic signaling pathways. This combined modality also increases the proportion of beneficial microbes (e.g., Bifidobacterium) and decreases the abundance of harmful microorganisms (e.g., Romboutsia) in the intestine. This treatment modality (CuxO@ZnO plus ultrasound and PD‐L1 antibodies) is a promising strategy for the synergistic treatment of colorectal cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Stress, Anesthesia, and Immune Response · Anesthesia and Neurotoxicity Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Urology Urologic Surgery Center Xinqiao Hospital Third Military Medical University (Army Medical University) Chongqing 400037 China

College of Sericulture Textile and Biomass Sciences Southwest University Chongqing 400715 China

Beijing Institute of Nanoenergy and Nanosystems Chinese Academy of Sciences Beijing 101400 China

3Bs Research Group I3Bs — Research Institute on Biomaterials Biodegradables and Biomimetics University of Minho Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine AvePark Barco Guimarães 4805‐017 Portugal

ICVS/3B's‐PT Government Associate Laboratory Guimarães Braga 4800‐058 Portugal

Department of Pharmacy Personalized Drug Therapy Key Laboratory of Sichuan Province Sichuan Provincial People's Hospital School of Medicine University of Electronic Science and Technology of China Chengdu 610054 China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · Venture and Innovation Support Program for Chongqing Overseas Returnees

References (64)

Show source-provided references
1. 10.1039/C9CS00648F10.1039/C9CS00648F ↗
2. 10.1002/advs.20230539210.1002/advs.202305392 ↗
3. 10.1021/acsnano.1c0061610.1021/acsnano.1c00616 ↗
4. 10.1016/j.nantod.2020.10094910.1016/j.nantod.2020.100949 ↗
5. 10.1002/adma.20230178410.1002/adma.202301784 ↗
6. 10.1002/adma.20160201210.1002/adma.201602012 ↗
7. 10.1021/acsnano.2c0196810.1021/acsnano.2c01968 ↗
8. 10.1002/adma.20230835510.1002/adma.202308355 ↗
9. 10.1002/adfm.20230257910.1002/adfm.202302579 ↗
10. 10.1038/s41467-023-40954-y10.1038/s41467-023-40954-y ↗
11. 10.1016/j.nantod.2022.10151010.1016/j.nantod.2022.101510 ↗
12. 10.1002/adfm.20190646610.1002/adfm.201906466 ↗
13. 10.1002/adma.20200845210.1002/adma.202008452 ↗
14. 10.1517/17425247.2010.50256010.1517/17425247.2010.502560 ↗
15. 10.3390/cancers1318457010.3390/cancers13184570 ↗
16. 10.1016/j.cej.2022.13503910.1016/j.cej.2022.135039 ↗
17. 10.1016/j.mtnano.2022.10017710.1016/j.mtnano.2022.100177 ↗
18. 10.3390/catal1201008410.3390/catal12010084 ↗
19. 10.1021/am401303810.1021/am4013038 ↗
20. 10.1007/s10971-015-3653-010.1007/s10971-015-3653-0 ↗
21. 10.1016/j.ccr.2021.21408710.1016/j.ccr.2021.214087 ↗
22. 10.1002/adfm.20230607810.1002/adfm.202306078 ↗
23. 10.7150/thno.3983110.7150/thno.39831 ↗
24. 10.1002/adma.20230951610.1002/adma.202309516 ↗
25. 10.1002/smll.20230592310.1002/smll.202305923 ↗
26. 10.1038/nri.2016.10710.1038/nri.2016.107 ↗
27. 10.34133/research.005210.34133/research.0052 ↗
28. 10.1002/advs.20210353410.1002/advs.202103534 ↗
29. 10.1016/j.ccr.2023.21553510.1016/j.ccr.2023.215535 ↗
30. 10.1021/acsnano.6b0665810.1021/acsnano.6b06658 ↗
31. 10.1002/hep.2920210.1002/hep.29202 ↗
32. 10.1016/j.apsb.2021.11.00510.1016/j.apsb.2021.11.005 ↗
33. 10.1038/s41568-022-00547-110.1038/s41568-022-00547-1 ↗
34. 10.1186/1476-4598-12-15210.1186/1476-4598-12-152 ↗
35. 10.1038/nrclinonc.2016.21710.1038/nrclinonc.2016.217 ↗
36. 10.1021/acsnano.8b0244610.1021/acsnano.8b02446 ↗
37. 10.1038/s41467-021-22572-810.1038/s41467-021-22572-8 ↗
38. 10.34133/research.010210.34133/research.0102 ↗
39. 10.1038/nri392110.1038/nri3921 ↗
40. 10.1172/JCI8689210.1172/JCI86892 ↗
41. 10.1158/1078-0432.CCR-15-136210.1158/1078-0432.CCR-15-1362 ↗
42. 10.1146/annurev-immunol-032713-12015610.1146/annurev-immunol-032713-120156 ↗
43. 10.1021/acs.chemrev.1c0075010.1021/acs.chemrev.1c00750 ↗
44. 10.1126/sciadv.abn391710.1126/sciadv.abn3917 ↗
45. 10.1038/s41591-022-01826-y10.1038/s41591-022-01826-y ↗
46. 10.34133/research.018810.34133/research.0188 ↗
47. 10.1002/smll.20120103310.1002/smll.201201033 ↗
48. 10.1039/D2CS00352J10.1039/D2CS00352J ↗
49. 10.1126/science.aar406010.1126/science.aar4060 ↗
50. 10.1016/S0092-8674(01)00456-110.1016/S0092-8674(01)00456-1 ↗
51. 10.1038/s41571-019-0175-710.1038/s41571-019-0175-7 ↗
52. 10.1016/j.biomaterials.2023.12228310.1016/j.biomaterials.2023.122283 ↗
53. 10.1186/s12943-019-0944-z10.1186/s12943-019-0944-z ↗
54. 10.1146/annurev-immunol-070119-11510410.1146/annurev-immunol-070119-115104 ↗
55. Wong S. H. · Hepatology · 2019 · 16 · 690
56. 10.3389/fimmu.2020.0090610.3389/fimmu.2020.00906 ↗
57. 10.1186/s12935-021-01971-310.1186/s12935-021-01971-3 ↗
58. 10.1016/j.fct.2020.11123710.1016/j.fct.2020.111237 ↗
59. 10.1016/j.chom.2021.03.01610.1016/j.chom.2021.03.016 ↗
60. 10.1007/s12029-023-00925-410.1007/s12029-023-00925-4 ↗
61. 10.1016/j.biomaterials.2019.05.01210.1016/j.biomaterials.2019.05.012 ↗
62. 10.1016/S0016-5085(03)01209-510.1016/S0016-5085(03)01209-5 ↗
63. 10.1038/s41467-019-09760-310.1038/s41467-019-09760-3 ↗
64. 10.1007/s13238-020-00707-910.1007/s13238-020-00707-9 ↗